Where does ReFlow Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ReFlow Medical, Inc. ranks #23,279 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ReFlow Medical, Inc. hold?

ReFlow Medical, Inc. holds 12 US utility patents granted between 2015 and 2025, spanning 4 technology areas.

What is ReFlow Medical, Inc.'s Innovation Score?

ReFlow Medical, Inc. has an Innovation Score of 41.1 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ReFlow Medical, Inc.'s patent grant rate increasing or decreasing?

ReFlow Medical, Inc.'s recent grant velocity is +133% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for ReFlow Medical, Inc.'s patents?

ReFlow Medical, Inc.'s patents average 19.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ReFlow Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ReFlow Medical, Inc.

Q: What technology areas does ReFlow Medical, Inc. focus on?

ReFlow Medical, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 8 patents, ranking #786 of 3,082 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 12 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Reflow ranks #23,279 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 4 technology areas.

#23,279
of 49,997 US assignees by volume: Top 34%
by Innovation Score (41.1/100): 19.7
avg claims per patent: +133%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23279 · US Corporation #23,279 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,279/49,997
PHOTO-FINISH Radians
CPC-NARROW A61F · 4 areas
INNOV-PAR 41.1/100
CLAIMS-RICH 19.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +133% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Radians, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Reflow’s 41.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (22%) Velocity 13.3 pts (32%) Breadth 7.1 pts (17%) Claim depth 11.8 pts (29%)

Qualcomm Incorporated · highest

85
ReFlow Medical · this assignee

41
3D Lighting… · lowest

7

What this shows Reflow's Innovation Score is 41.1/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Reflow?

Each dot is one of Reflow’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Reflow’s own 19.7 claims/patent is ABOVE the 15.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Reflow vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Reflow's grants concentrate

ReFlow Medical, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 66.7% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2015. By volume, Reflow sits between Radians, Inc. and Red Bank Technologies LLC.

Reflow's three-year grant acceleration

ReFlow Medical, Inc. shows 6 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Radians

12
Ragner Technology

12
Ransburg Industri…

12
Ravenwhite Securi…

12
Remynd

12
Reactive Surfaces…

12
Real Innovations…

12
Red Bank

12
Reflow Medical ◀

12

What this shows ReFlow holds 12 patents at rank #23,289, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ReFlow

By rank, the assignees closest to #23,289 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in ReFlow's primary technology class.

Reflow's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ReFlow Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	8.3%
2019	2	16.7%
2020	1	8.3%
2022	2	16.7%
2023	2	16.7%
2024	2	16.7%
2025partial year	2	16.7%

Which technologies does ReFlow Medical, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 8

A61B - DIAGNOSIS; SURGERY; Identification 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 4

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ReFlow Medical, Inc.'s patent record in context - here's where to go next.

ReFlow Medical, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 66.7% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #23,279 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ReFlow Medical, Inc. against Radians, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.